AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27236889
Drug: Qingfei Quyu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingfei Quyu Decoction (QQD), one dose per day for 8 weeks
Trial: 24799484
Drug: CVI FU
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVI FU (225 mg/m2, 5 days per week)
Trial: 24799484
Drug: Capecitabine (825
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (825 mg/m2, twice per day, 5 days per week)
Trial: 24799484
Drug: CVI FU
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVI FU with oxaliplatin (50 mg/m2 once per week for 5 weeks)
Trial: 24799484
Drug: Capecitabine with
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine with oxaliplatin (50 mg/m2 once per week for 5 weeks)
Trial: 24799484
Drug: Oxaliplatin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxaliplatin (50 mg/m2 once per week for 5 weeks)
Trial: 17483955
Drug: MRI per
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRI per OS with 6% mannitol solution
Trial: 17483955
Drug: MRE with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRE with nasojejunal intubation and polyethylenglycol solution
Trial: 12499885
Drug: Stop group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stop group (STOP) - 10 mg prednisolone stopped after day 7 posttransplantation
Trial: 12499885
Drug: Tapering group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering group (TAP) - Gradually wean off steroids in 3 to 6 months
Trial: 9585276
Drug: Morphine continuous
RxNorm normalized name: morphine sulfate Oral Suspension [MST Continus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine continuous intravenous infusion after a loading dose of 0.05 mg/kg, aiming for a steady-state concentration of 20 ng/mL.
Trial: 9585276
Drug: Morphine continuous
RxNorm normalized name: morphine sulfate Oral Suspension [MST Continus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine continuous intravenous infusion after a loading dose of 0.05 mg/kg.
Trial: 2664258
Drug: Roxithromycin (RU)
RxNorm normalized name: roxithromycin
DrugBank: Roxithromycin (DB00778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin (RU) 300 mg daily for 3 to 7 days
Trial: 2664258
Drug: Josamycin (JM)
RxNorm normalized name: josamycin
DrugBank: Josamycin (DB01321)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Josamycin (JM) 1200 mg daily for 3 to 7 days
Trial: 25585664
Drug: etravirine plus
RxNorm normalized name: Etravirine
DrugBank: Etravirine (DB06414)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: etravirine plus an alternative boosted protease inhibitor (other PI group)
Trial: 23850111
Drug: Intervention program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention program including physical exercise, recreational activities, and nutritional counseling for 12 weeks (three times weekly)
Trial: 21831277
Drug: Monthly health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly health education workshops alone (Group 1)
Trial: 21831277
Drug: Monthly health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly health education workshops combined with family orientation through home visits (Group 2)
Trial: 17069496
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) for 10 sessions per day excluding weekends
Trial: 9007680
Drug: Lisinopril 20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 20 mg (B)
Trial: 9007680
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose (D)
Trial: 22324516
Drug: Levetiracetam extended-release
RxNorm normalized name: Levetiracetam Extended-Release Tablets
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam extended-release (XR)
Trial: 9241288
Drug: TRH infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH infusion (400 micrograms)
Trial: 31264787
Drug: Group cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive behavioural therapy (GCBT)
Trial: 27619827
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg long-acting octreotide once every 4 weeks for 52 weeks
Trial: 27619827
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg long-acting octreotide
Trial: 22447019
Drug: No aspirin
RxNorm normalized name: XS No Aspirin PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No aspirin therapy
Trial: 1463171
Drug: Prewarmed local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prewarmed local anaesthetic solution (37 degrees C)
Trial: 1463171
Drug: Room temperature
RxNorm normalized name: ROOM DEODORIZER POWDER MENTOR #3202
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Room temperature local anaesthetic solution (25 degrees C)
Trial: 19282124
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg lopinavir + 50 mg ritonavir tablet formulation
Trial: 17975231
Drug: N-acetylcysteine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (100 mg/kg i.v. bolus, 20 mg/kg/hr infusion until four hours after cardiopulmonary bypass)
Trial: 11041902
Drug: Meloxicam 3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 3.75 mg/d
Trial: 11041902
Drug: Meloxicam 7.5
RxNorm normalized name: meloxicam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 7.5 mg/d
Trial: 11041902
Drug: Meloxicam 15
RxNorm normalized name: meloxicam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 15 mg/d
Trial: 11041902
Drug: Diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 100 mg (50 mg twice daily)
Trial: 8977598
Drug: Budesonide 800
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 800 micrograms twice daily plus terbutaline 1000 micrograms three times daily
Trial: 30120640
Drug: Control (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0.9% saline injections)
Trial: 24756739
Drug: Mat Pilates
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mat Pilates programme (8 weeks, 3 times weekly)
Trial: 24756739
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (maintained normal daily activities)
Trial: 8640997
Drug: Diuretic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic therapy (hydrochlorothiazide plus amiloride)
Trial: 8640997
Drug: Placebo transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo transdermal nitroglycerin
Trial: 1639045
Drug: Glycogen depletion
RxNorm normalized name: glycogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycogen depletion treatment (exercise + low-carbohydrate high-fat diet)
Trial: 1639045
Drug: Glycogen repletion
RxNorm normalized name: glycogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycogen repletion treatment (exercise + high carbohydrate diet)
Trial: 1639045
Drug: Diet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet treatment (low-carbohydrate high-fat diet alone)
Trial: 24327422
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for spinal metastasis post-RCT
Trial: 21904945
Drug: Active control
RxNorm normalized name: Accu-Chek Active Control Solution
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active control arm with access to an eJournal for medications, allergies, and diabetes management
Trial: 19042044
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d atorvastatin (statin group 1)
Trial: 19042044
Drug: 20 mg/d
RxNorm normalized name: Valtoco, 20 mg/dose nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/d atorvastatin (statin group 2)
Trial: 18779613
Drug: Oral etoposide
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral etoposide plus carboplatin (EC)
Trial: 15925032
Drug: Intranasally administered
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasally administered Cholecystokinin (CCK)
Trial: 10550374
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with three cycles of carboplatin/5-FU prior to surgery and radiotherapy (arm A)
Trial: 8908387
Drug: Intraperitoneal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal insulin injection (0.15 units/kg body wt)
Trial: 8908387
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin injection (0.15 units/kg body wt)
Trial: 28207516
Drug: Weekly SMS
RxNorm normalized name: Samarium Sm-153
DrugBank: Samarium Sm-153 (DB12905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly SMS interventions
Trial: 21129337
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (5 g glucose, 0.5 U insulin)
Trial: 21129337
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose (10 g glucose, 1 U insulin)
Trial: 21129337
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (20 g glucose, 2 U insulin)
Trial: 21129337
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses tested
Trial: 11856075
Drug: Budesonide enema
RxNorm normalized name: budesonide Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide enema (2 mg/100 mL at bedtime)
Trial: 11856075
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole (0.5 g b.d.)
Trial: 9642517
Drug: C2: 200-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C2: 200-400 ng/ml
Trial: 9642517
Drug: C0: 100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C0: 100-200 ng/ml
Trial: 8608684
Drug: Diclofenac (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (50 mg three times daily)
Trial: 2681495
Drug: Sodium meclofenamate
RxNorm normalized name: Meclofenamate Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium meclofenamate (Meclomen) 100 mg, p.os, t.i.d.
Trial: 30532984
Drug: 36 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 36 Gy whole-breast and 40 Gy partial-breast radiotherapy (reduced-dose)
Trial: 28398471
Drug: Higher amounts
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher amounts of joule energy and treatment planes
Trial: 28398471
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment with lower joule energy and treatment planes
Trial: 20888091
Drug: Iron (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron (100 mg/day as ferrous sulphate) and folic acid (500 μg/day) supplementation
Trial: 20888091
Drug: Placebo (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (100 mg cane sugar)
Trial: 16413752
Drug: High-dose creatine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose creatine supplementation (20 g/d for 1 week)
Trial: 16413752
Drug: Low-dose creatine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose creatine supplementation (5 g/d for 20 weeks)
Trial: 8967707
Drug: Cloxacillin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cloxacillin alone (2 g intravenously every 4 hours for 14 days)
Trial: 8967707
Drug: Cloxacillin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cloxacillin plus gentamicin (1 mg/kg intravenously every 8 hours for 7 days)
Trial: 29949889
Drug: Low-molecular-weight Collagen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight Collagen peptide (LMWCP) 1000 mg once daily for 12 weeks
Trial: 22694755
Drug: Steroid-free (SF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free (SF) immunosuppression (subgroup under 5 years)
Trial: 22694755
Drug: Steroid-based (SB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-based (SB) immunosuppression (subgroup under 5 years)
Trial: 19962115
Drug: Group phone-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group phone-based treatment
Trial: 19962115
Drug: Individual phone-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual phone-based treatment
Trial: 10467921
Drug: Hypnotic suggestions
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestions to decrease pain affect (Experiment one)
Trial: 10467921
Drug: Hypnotic suggestions
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestions to increase and decrease pain affect (Experiment two)
Trial: 10467921
Drug: Hypnotic suggestions
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestions to modulate sensory aspect of pain (Experiment three)
Trial: 8546501
Drug: Drug use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug use during pregnancy
Trial: 231914
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg tubocurarine
Trial: 231914
Drug: 0.04 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.04 mg/kg pancuronium bromide
Trial: 22679722
Drug: Chinese medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medical facial mask (twice a week for 4 weeks)
Trial: 22679722
Drug: 5% benzoyl
RxNorm normalized name: BENZOYL PEROXIDE 2.5 g in 100 mL TOPICAL SOAP [Benzoyl Acne Wash -2.5% Benzoyl Peroxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% benzoyl peroxide gel (once in the evening for 4 weeks)
Trial: 20885412
Drug: Xylitol chewing
RxNorm normalized name: xylitol Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylitol chewing gum twice a day after breakfast and lunch (G1)
Trial: 20885412
Drug: Fluoride gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride gel application (G4)
Trial: 18163038
Drug: rTMS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTMS treatment for major depressive disorder (MDD)
Trial: 2021297
Drug: Carbamazepine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (200 to 800 mg/d)
Trial: 6122846
Drug: Freshly prepared
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freshly prepared penicillin-G solution administered as a bolus
Trial: 6122846
Drug: Penicillin-G solution
RxNorm normalized name: penicillin G
DrugBank: Benzylpenicillin (DB01053)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin-G solution stored for a few hours
Trial: 31907027
Drug: Scalp acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scalp acupuncture combined with conventional rehabilitation treatment
Trial: 31907027
Drug: Conventional rehabilitation
RxNorm normalized name: GLUTATHIONE 12.5 g in 100 mL ORAL LIQUID [K2LTS Brain Rehabilitation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional rehabilitation treatment alone
Trial: 30232416
Drug: Circadian phase
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Circadian phase (biological evening)
Trial: 20500899
Drug: Vernonia cinerea
RxNorm normalized name: vernonia cinerea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vernonia cinerea (VC) supplement
Trial: 20500899
Drug: Exercise with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise with VC supplement
Trial: 17650659
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group vs control group
Trial: 7750528
Drug: Intravesical bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical bacillus Calmette‐Guerin (BCG) immunotherapy
Trial: 7750528
Drug: Maintenance BCG
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance BCG using three weekly treatments at 6-month intervals
Trial: 2246098
Drug: Maharishi Amrit
RxNorm normalized name: Amrix
DrugBank: Cyclobenzaprine (DB00924)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maharishi Amrit Kalash (MAK) tablets, twice daily for six weeks
Trial: 2246098
Drug: Placebo, twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, twice daily for six weeks
Trial: 27791311
Drug: Platelets rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelets rich plasma injections
Trial: 24688618
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care (education, pharmacotherapy monitoring, detecting and solving drug related problems)
Trial: 24688618
Drug: Standard pharmaceutical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pharmaceutical services (dispensing medicines with or without counseling)
Trial: 16886928
Drug: Dipyridamole 0.142
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole 0.142 mg/kg per min administered intravenously
Trial: 15363419
Drug: Intradiscal steroid
RxNorm normalized name: CHYMOPAPAIN 2nKatU/ML INTRADISCAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradiscal steroid injections (ISI)
Trial: 15363419
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid injections (ESI) in patients with inflammatory end‐plate changes
Trial: 15363419
Drug: Discography with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discography with or without intradiscal steroid
Trial: 3874037
Drug: Fluoxetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (30 or 60 mg) with ethanol (45 ml absolute alcohol per 70 kg body weight)
Trial: 31679186
Drug: Control (current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (current antiretroviral therapy)
Trial: 19590475
Drug: Nortriptyline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline (10 mg daily increment over 1 week to 50 mg)
Trial: 17334477
Drug: Cabergoline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (0.5 mg once a week for 6 weeks)
Trial: 17334477
Drug: Diphereline (3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphereline (3.75 mg 4 times every 28 days)
Trial: 14973304
Drug: Aprepitant 125
RxNorm normalized name: aprepitant 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant 125 mg p.o. on day 1 and 80 mg p.o. on days 2 and 3
Trial: 11253520
Drug: One-stage ventro-dorsal
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-stage ventro-dorsal procedure in combination with VDS and MPDS
Trial: 30197040
Drug: Intradermal BCG
RxNorm normalized name: Tice BCG Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal BCG vaccine prior to standard intravesical BCG
Trial: 26210166
Drug: Intravenous fosaprepitant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fosaprepitant 150 mg (NK1 group)
Trial: 26210166
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg (ONS group)
Trial: 24283179
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 20 mg/daily for ten days
Trial: 18080059
Drug: Naltrexone (Revia)
RxNorm normalized name: naltrexone Oral Tablet [ReVia]
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone (Revia) or acamprosate (Campral) or both medications and/or placebos in combination with medical management (MM), with or without combined behavioral intervention (CBI)
Trial: 18080059
Drug: CBI without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBI without MM or pills
Trial: 17318795
Drug: Telmisartan (Telm)
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan (Telm) 80 mg + Rosiglitazone (RSG) 4 mg
Trial: 17318795
Drug: Amlodipine (Aml)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (Aml) 10 mg + Rosiglitazone (RSG) 4 mg
Trial: 1532336
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly amorolfine 5% nail lacquer